Shrinking the battlefield in cancer therapy: Nanotechnology against cancer stem cells
Author | Queenie, Fernandes |
Author | Therachiyil, Lubna |
Author | Khan, Abdul Q. |
Author | Bedhiafi, Takwa |
Author | Korashy, Hesham M |
Author | Bhat, Ajaz A. |
Author | Uddin, Shahab |
Available date | 2024-01-29T11:01:03Z |
Publication Date | 2023-09-19 |
Publication Name | European Journal of Pharmaceutical Sciences |
Identifier | http://dx.doi.org/10.1016/j.ejps.2023.106586 |
Citation | Fernandes, Q., Therachiyil, L., Khan, A. Q., Bedhiafi, T., Korashy, H. M., Bhat, A. A., & Uddin, S. (2023). Shrinking the Battlefield in Cancer Therapy: Nanotechnology Against Cancer Stem Cells. European Journal of Pharmaceutical Sciences, 106586. |
ISSN | 0928-0987 |
Abstract | Cancer remains one of the leading causes of mortality worldwide, presenting a significant healthcare challenge owing to the limited efficacy of current treatments. The application of nanotechnology in cancer treatment leverages the unique optical, magnetic, and electrical attributes of nanomaterials to engineer innovative, targeted therapies. Specifically, manipulating nanomaterials allows for enhanced drug loading efficiency, improved bioavailability, and targeted delivery systems, reducing the non-specific cytotoxic effects characteristic of conventional chemotherapies. Furthermore, recent advances in nanotechnology have demonstrated encouraging results in specifically targeting CSCs, a key development considering the role of these cells in disease recurrence and resistance to treatment. Despite these breakthroughs, the clinical approval rates of nano-drugs have not kept pace with research advances, pointing to existing obstacles that must be addressed. In conclusion, nanotechnology presents a novel, powerful tool in the fight against cancer, particularly in targeting the elusive and treatment-resistant CSCs. This comprehensive review delves into the intricacies of nanotherapy, explicitly targeting cancer stem cells, their markers, and associated signaling pathways. |
Sponsor | Open access is provided by Qatar National Library. |
Language | en |
Publisher | Elsevier |
Subject | Nanotherapy Cancer stem cells Signaling pathways Pharmacokinetics Drug resistance |
Type | Article |
Volume Number | 191 |
Open Access user License | http://creativecommons.org/licenses/by/4.0/ |
ESSN | 1879-0720 |
Check access options
Files in this item
This item appears in the following Collection(s)
-
Laboratory Animal Research Center (Research) [96 items ]
-
Medicine Research [1418 items ]
-
Pharmacy Research [1261 items ]